Community Research and Development Information Service - CORDIS

New hope for the PAH patient: A Novel Therapeutic for Pulmonary Arterial Hypertension (PAH)

From 2018-10-01 to 2020-09-30, ongoing project

Project details

Total cost:

EUR 3 570 000

EU contribution:

EUR 2 499 000

Coordinated in:

Ireland

Call for proposal:

H2020-SMEInst-2018-2020-2See other projects for this call

Funding scheme:

SME-2 - SME instrument phase 2

Objective

Coordinator

ATXA THERAPEUTICS LTD
Ireland

EU contribution: EUR 2 499 000


75 AVOCA PARK AVOCA AVENUE BLACKROCK
A94 N803 DUBLIN
Ireland
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)

Contact the organisation

Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top